Want to join the conversation?
$STZ 1Q16 Call – David, CFO: 1Q16 Highlights: On a comparable basis, diluted EPS was up 18%; paid a quarterly dividend first time in our history; and continued robust marketplace momentum for our Beer business along with our agreement to acquire the Meiomi wine brand are driving our FY16 comparable basis diluted EPS of $0.10 to a range of $4.80-5.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?